Heart attack patients with rare artery condition may benefit from new blood thinner combo
NCT ID NCT07511257
First seen May 07, 2026 · Last updated May 07, 2026
Summary
This study tests whether adding a blood thinner (rivaroxaban) to a single antiplatelet drug (clopidogrel) works better than the standard two antiplatelet drugs (aspirin plus clopidogrel) for people with acute coronary syndrome and a condition called coronary artery ectasia, where the heart arteries are abnormally widened. About 326 adults hospitalized after a heart attack will be randomly assigned to one of the two treatments and followed for up to a year. The goal is to see if the new combination reduces major heart problems like another heart attack or need for repeat procedures, without causing more dangerous bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEMI - ST ELEVATION MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Instituto Nacional de Cardiologia "Ignacio Chávez"
RECRUITINGMexico City, Tlalpan, 14080, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.